These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 27498697

  • 1. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
    Mao X, Qiao Z, Fan C, Guo A, Yu X, Jin F.
    Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
    [Abstract] [Full Text] [Related]

  • 2. p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women.
    Mao XY, Fan CF, Zheng HC, Wei J, Yao F, Jin F.
    J Exp Clin Cancer Res; 2010 Aug 16; 29(1):112. PubMed ID: 20712900
    [Abstract] [Full Text] [Related]

  • 3. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N, Sun ZZ, Li F, Cao YW, Zhao CX, Liang WH, Sun HP, Li HA, Fu XG.
    Zhonghua Bing Li Xue Za Zhi; 2011 May 16; 40(5):324-9. PubMed ID: 21756827
    [Abstract] [Full Text] [Related]

  • 4. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S, Wei B, Zhang H, Qing M, Bu H.
    Oncol Rep; 2008 Jun 16; 19(6):1469-75. PubMed ID: 18497952
    [Abstract] [Full Text] [Related]

  • 5. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
    Martinez AP, Cohen C, Hanley KZ, Li XB.
    Arch Pathol Lab Med; 2016 Jul 16; 140(7):686-9. PubMed ID: 27116088
    [Abstract] [Full Text] [Related]

  • 6. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
    Niu F, Wang L, Zhang W, Lyu S, Niu Y.
    Zhonghua Zhong Liu Za Zhi; 2015 Oct 16; 37(10):749-52. PubMed ID: 26813593
    [Abstract] [Full Text] [Related]

  • 7. Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.
    Zhou CJ, Zhang QH, Zhang TG, Sun SZ, Li H, Wang Y, Liu ZY.
    Pathol Oncol Res; 2009 Jun 16; 15(2):153-8. PubMed ID: 18941930
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
    Simooka H, Oyama T, Sano T, Horiguchi J, Nakajima T.
    Pathol Int; 2004 Aug 16; 54(8):595-602. PubMed ID: 15260850
    [Abstract] [Full Text] [Related]

  • 9. A study of the role of Notch1 and JAG1 gene methylation in development of breast cancer.
    Sun H, Li K, Shen S.
    Med Oncol; 2016 Apr 16; 33(4):35. PubMed ID: 26971121
    [Abstract] [Full Text] [Related]

  • 10. [Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].
    Zhang JL, Zhang HY, Wei B, Lang ZQ, Bu H.
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug 16; 33(4):316-9. PubMed ID: 15363314
    [Abstract] [Full Text] [Related]

  • 11. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA, Ismail WM, Abdelhamid MS, Nabil TM, Daoud SA.
    Asian Pac J Cancer Prev; 2016 Aug 16; 17(8):3733-6. PubMed ID: 27644608
    [Abstract] [Full Text] [Related]

  • 12. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Satomi S, Sasano H.
    Anticancer Res; 2000 Aug 16; 20(2B):1101-8. PubMed ID: 10810403
    [Abstract] [Full Text] [Related]

  • 13. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH.
    Virchows Arch; 2011 Jan 16; 458(1):73-84. PubMed ID: 21120523
    [Abstract] [Full Text] [Related]

  • 14. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
    Omi Y, Yamamoto T, Okamoto T, Obara T, Kobayashi M.
    Histol Histopathol; 2011 Jan 16; 26(1):79-86. PubMed ID: 21117029
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor β2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions.
    Chantzi NI, Palaiologou M, Stylianidou A, Goutas N, Vassilaros S, Kourea HP, Dhimolea E, Mitsiou DJ, Tiniakos DG, Alexis MN.
    J Cancer Res Clin Oncol; 2014 Jun 16; 140(6):1057-66. PubMed ID: 24671226
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
    Rahko E, Kauppila S, Pääkkö P, Blanco G, Apaja-Sarkkinen M, Talvensaari-Mattila A, Turpeenniemi-Hujanen T, Jukkola A.
    Tumour Biol; 2009 Jun 16; 30(5-6):257-64. PubMed ID: 19887890
    [Abstract] [Full Text] [Related]

  • 17. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.
    Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO.
    Am J Surg Pathol; 2007 Mar 16; 31(3):417-26. PubMed ID: 17325484
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Sasano H.
    Jpn J Cancer Res; 2000 Nov 16; 91(11):1169-76. PubMed ID: 11092983
    [Abstract] [Full Text] [Related]

  • 19. The Utility of SOX10 Immunohistochemical Staining in Breast Pathology.
    Rammal R, Goel K, Elishaev E, Rinda Soong T, Jones MW, Zhao C, Clark BZ, Carter GJ, Yu J, Fine JL, Villatoro TM, Harinath L, Bhargava R.
    Am J Clin Pathol; 2022 Nov 03; 158(5):616-625. PubMed ID: 36000970
    [Abstract] [Full Text] [Related]

  • 20. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT, Koerner FC, Lerwill MF.
    Hum Pathol; 2006 Jul 03; 37(7):787-93. PubMed ID: 16784976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.